360 Participants Needed

Care Navigation for Addiction

(ABC-SUD Trial)

JE
CJ
TB
TE
TB
Overseen ByTara Beatty, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Kaiser Permanente
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a new approach called Care Navigation, a personalized support service, can assist individuals in adhering to their substance use disorder treatment. Typically, patients receive basic information and referrals from care coordinators at a mental health center. In this trial, patients may also receive assistance from a care navigator, who provides more personalized support. Individuals who have had a treatment planning visit for substance use disorder with a care coordinator at Kaiser Permanente might be suitable candidates. As an unphased trial, this study offers a unique opportunity to explore personalized support options that could enhance the treatment journey.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on care navigation for substance use disorder treatment.

What prior data suggests that Care Navigation is safe for patients with substance use disorder?

Research has shown that care navigation, which assists individuals with substance use issues in finding and accessing treatment, can be beneficial. In similar contexts, care navigation has been linked to improved health outcomes and fewer hospital visits. Studies indicate that when individuals with multiple health problems receive assistance navigating the healthcare system, they report greater satisfaction with their care.

These findings suggest that care navigation is generally safe and does not pose significant risks to participants. This approach has been used in other areas without major safety concerns. Although this trial's phase is "Not Applicable," indicating it doesn't fit into the usual clinical trial stages, using care navigation for similar purposes has demonstrated promise in terms of safety and effectiveness.12345

Why are researchers excited about this trial?

Researchers are excited about the Care Navigation approach for addiction because it goes beyond traditional methods by integrating care navigators into the treatment process. Unlike standard care, which typically involves providing substance use resources and treatment options directly, this approach adds a dedicated care navigator to help guide patients through their recovery journey. This personalized support can potentially improve treatment adherence and outcomes by ensuring patients receive the right care at the right time, addressing barriers to recovery, and providing a more tailored approach to managing addiction.

What evidence suggests that Care Navigation is effective for increasing engagement in substance use disorder treatment?

Research has shown that having a care navigator, which participants in this trial may receive, can improve outcomes for people with substance use disorder (SUD). This trial will compare the Care Navigation approach with Services as Usual. Studies have found that similar methods, such as social prescribing, improve healthcare quality and reduce hospital visits for people with various health issues. Care coordination, which involves helping patients find resources and support, has successfully improved SUD treatment outcomes. This evidence suggests that a care navigator could enhance patient engagement with SUD treatment by providing personalized guidance and support.13567

Who Is on the Research Team?

JE

Joseph E Glass, PhD MSW

Principal Investigator

Chestnut Health Systems

Are You a Good Fit for This Trial?

This trial is for individuals seeking treatment for substance use disorders at a mental health access center within the Washington region of Kaiser Permanente. Participants must be contacting the center to get an appointment or information about treatment options.

Inclusion Criteria

Clinician has completed trainings related to their clinical role in the health system
Patient visits an enrolled care coordinator during the patient eligibility period
Patient has an assessment and treatment planning visit for SUD with an enrolled care coordinator
See 3 more

Exclusion Criteria

Patients who have requested through the health system to opt out of research contact or chart review
I am not covered by Kaiser Permanente or Medicaid insurance.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Period 1: Services as Usual

Care coordinators offer substance use resources and treatment options as usual

Approximately half of the trial duration

Period 2: Care Navigation

Care coordinators offer care navigation and refer patients to care navigators

Approximately half of the trial duration

Follow-up

Participants are monitored for engagement in substance use disorder treatment

48 days

What Are the Treatments Tested in This Trial?

Interventions

  • Care Navigation
Trial Overview The study tests 'Care Navigation'—a support process by special care navigators aimed at improving patient engagement in substance use disorder treatments, compared to usual care coordination.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Care NavigationExperimental Treatment1 Intervention
Group II: Services as UsualActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kaiser Permanente

Lead Sponsor

Trials
563
Recruited
27,400,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Published Research Related to This Trial

Nurse navigation in cancer care has been associated with significant improvements in clinical outcomes, including reduced distress, anxiety, and depression among patients.
Patients receiving nurse navigation experienced better symptom management, improved physical conditioning, enhanced quality of life, and quicker initiation of treatment, highlighting the effectiveness of this approach in cancer care.
Clinical outcomes of patient navigation performed by nurses in the oncology setting: an integrative review.Rodrigues, RL., Schneider, F., Kalinke, LP., et al.[2022]
Separating addiction care from general medical care leads to poorer quality of medical treatment for patients with substance use issues, highlighting the need for better integration.
Strategies to improve care coordination include engaging patients in general medical settings, managing substance use disorders in primary care, incorporating family perspectives, and developing payment models that support integrated care.
A Research Agenda to Advance the Coordination of Care for General Medical and Substance Use Disorders.Quinn, AE., Rubinsky, AD., Fernandez, AC., et al.[2018]
Among 572,582 patients in community health centers, only 3.0% had documented alcohol use disorders (AUDs) and 1.1% had opioid use disorders (OUDs), indicating a significant prevalence of substance use disorders in this population.
Medication-assisted treatments (MAT) for AUDs and OUDs were underprescribed, with only 3.2% of AUD patients and 29.0% of OUD patients receiving MAT, despite MAT being associated with increased screening for HIV and hepatitis C.
Medication-assisted treatment for substance use disorders within a national community health center research network.Rieckmann, T., Muench, J., McBurnie, MA., et al.[2018]

Citations

Effect of social prescribing link workers on health outcomes ...Two US studies found improved ratings of high-quality care and reduced hospitalisations for people with multimorbidity experiencing deprivation.
Effectiveness and active ingredients of social prescribing ...This study aims to establish the effectiveness and active ingredients of UK-based social prescribing interventions targeting mental health and well-being ...
The effectiveness of social prescribing in the management ...The objective of this systematic review and meta-analysis was to evaluate the effectiveness of social prescribing interventions in the management of long-term ...
Social prescribing in the USA: emerging learning and ...We outline some of the different forms that social prescribing is taking across the USA, which draws on 23 programmes we identified across 11 states that ...
Care Coordination Strategies for Patients Can Improve ...This document outlines key components of various models that use care coordination to improve outcomes for patients with SUD and discusses two examples—the ...
CAMHS and Social Prescribing Applications (CASPA)These trials gather additional information about a drug's safety, efficacy, or optimal use. Phase Not Applicable. Describes trials without FDA-defined phases ...
Care Navigation for Methamphetamine Addiction ...The available research shows that coordinating care for substance use disorders, like methamphetamine addiction, can lead to better health outcomes. For example ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security